Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Algerian gastric cancer study aims to map diagnosis and care

NCT ID NCT07481110

Knowledge-focused Sponsor: Société Algérienne de Formation et Recherche en Oncologie Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This observational study will follow 1,000 adults in Algeria who have been diagnosed with gastric cancer. Researchers will collect information on patient demographics, risk factors, symptoms, how the cancer is diagnosed, and what treatments are used. The goal is to better understand the current state of gastric cancer care in Algeria and identify areas for improvement.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could provide a clearer picture of how gastric cancer is diagnosed and managed in Algeria, helping to improve future care guidelines.
What could go wrong
This is an observational study, not a treatment trial, so it will not directly test any new therapy. The results may not apply to other countries or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2025

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with histologically confirmed gastric cancer, followed in the participating oncology departments.

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 19 years and older * Histologically confirmed diagnosis of gastric cancer * Patients followed in the participating oncology departments * Informed consent obtained Non Inclusion Criteria: * Histological types other than carcinoma (e.g., GIST, lymphoma, sarcoma, etc.). * Secondary gastric tumors * Participation in an interventional study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gastric (stomach) cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

disease gastric cancer gastric neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gastric (stomach) cancer Gastric cancer Gastric cancer (diagnosis)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    15 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CAC DBK

    NOT_YET_RECRUITING

    Tizi Ouzou, Algeria

    Contact Email: •••••@•••••

  • CAC Oran

    NOT_YET_RECRUITING

    Oran, Algeria

    Contact Email: •••••@•••••

  • CAC Oued Souf

    NOT_YET_RECRUITING

    El Oued, Algeria

    Contact Email: •••••@•••••

  • CAC Sidi Bel Abbès

    NOT_YET_RECRUITING

    Sidi Bel Abbes, Algeria

    Contact Email: •••••@•••••

  • CAC Sétif

    NOT_YET_RECRUITING

    Sétif, Algeria

    Contact Email: •••••@•••••

  • CHU Annaba

    NOT_YET_RECRUITING

    Annaba, Algeria

    Contact Email: •••••@•••••

  • CHU Béni Messous

    RECRUITING

    Algiers, Algeria, 16000, Algeria

    Contact Email: •••••@•••••

  • CHU Constantine

    NOT_YET_RECRUITING

    Constantine, Algeria

    Contact Email: •••••@•••••

  • CHU Oran

    NOT_YET_RECRUITING

    Oran, Algeria

    Contact Email: •••••@•••••

  • CPMC

    NOT_YET_RECRUITING

    Algiers, Algeria

    Contact Email: •••••@•••••

  • Cac Blida

    NOT_YET_RECRUITING

    Algiers, Algeria, 16000, Algeria

    Contact Email: •••••@•••••

  • EHU Oran

    NOT_YET_RECRUITING

    Oran, Algeria

    Contact Email: •••••@•••••

  • EPH Constantine

    NOT_YET_RECRUITING

    Constantine, Algeria

    Contact Email: •••••@•••••

  • EPH Rouiba

    NOT_YET_RECRUITING

    Algiers, Algeria

    Contact Email: •••••@•••••

  • EPH Sidi Ghiles

    NOT_YET_RECRUITING

    Tipasa, Algeria

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.